| Literature DB >> 20123621 |
Abstract
OBJECTIVE: Epidemiologic studies of air pollution effects on respiratory health report significant modification by sex, although results are not uniform. Importantly, it remains unclear whether modifications are attributable to socially derived gendered exposures, to sex-linked physiological differences, or to some interplay thereof. Gender analysis, which aims to disaggregate social from biological differences between males and females, may help to elucidate these possible sources of effect modification. DATA SOURCES AND DATA EXTRACTION: A PubMed literature search was performed in July 2009, using the terms "respiratory" and any of "sex" or "gender" or "men and women" or "boys and girls" and either "PM2.5" (particulate matter <or= 2.5 microm in aerodynamic diameter) or "NO2" (nitrogen dioxide). I reviewed the identified studies, and others cited therein, to summarize current evidence of effect modification, with attention to authors' interpretation of observed differences. Owing to broad differences in exposure mixes, outcomes, and analytic techniques, with few studies examining any given combination thereof, meta-analysis was not deemed appropriate at this time. DATA SYNTHESIS: More studies of adults report stronger effects among women, particularly for older persons or where using residential exposure assessment. Studies of children suggest stronger effects among boys in early life and among girls in later childhood.Entities:
Mesh:
Year: 2010 PMID: 20123621 PMCID: PMC2831913 DOI: 10.1289/ehp.0900994
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Possible roles of gender and sex in shaping observed relationships between air pollution and health. Gender affects the presence of the exposure itself (e.g., cosmetic use), whereas biological sex differences determine the consequent dose (e.g., through dermal thickness and permeability). Sex differences in biological transport and target organs determine health outcomes, potentially modified by gendered (behavioral) coexposures and their sequelae.
Studies examining effect modification by sex among adults.
| Study | Population | Exposure metric(s) | Outcome(s) | Risk among males | Risk among females |
|---|---|---|---|---|---|
| Studies reporting stronger effects among women | |||||
| 1.3 million deaths, 27 U.S. cities 1997–2002 | Prior day PM2.5 > 10 μg/m3 | Percent increase in respiratory mortality | 1.90 (0.14–3.65) | 1.57% (−0.22 to −3.35) | |
| Daily deaths in Chicago, IL 1985–1990 | Daily PM10, O3 at nearest regulatory monitor | RR for respiratory mortality | RR = 1.10 (0.97–1.26) | RR = 1.17 (1.02–1.35) | |
| 15,792 middle-age U.S. adults, 1987–1989 (ARIC cohort) | Quartiles of residential traffic density | Lung function: FEV1 | β (Q4, age adjusted) = 19.6 (−34.9 to 74.1); | β (Q4, age adjusted) = −34.8 (−66.5 to −3.1); | |
| Adult population of Shanghai, China (population, 13.1 million) | 10-μg/m3 increase in daily PM10, SO2, NO2, O3 | Percent increase in respiratory mortality | β (PM10) = 0.17% (0.03 to 0.32) | β (PM10) = 0.33% (0.18–0.48) | |
| 1,602 adults (15–64 years) in Windsor, Ontario, Canada 1995–2000 | IQR increase in 1-, 2-, 3-day lag NO2, SO2, CO, COH, O3, PM10, TRS | Risk of respiratory hospitalization | RR (2-day COH) = 1.04 (0.82–1.32) | RR (2-day COH) = 1.20 (1.00–1.43), by case crossover | |
| 2,305 adults (≥ 35 years of age) Spain, 1985–1989 | 20-μg/m3 increase in same-day ambient black smoke | Respiratory mortality | OR = 1.14 (0.98–1.33) | OR = 1.52 (0.99, 2.31) | |
| 3,232 men and 3,592 women in Europe | Constant traffic density | Prevalence of chronic phlegm | β (traffic) = 6.13% (4.37–8.32); | β (traffic) = 7.69% (5.95–9.75); | |
| 142 lifeguards 16–27 years of age (79% male) | 10-μg/m3 increase daily average PM2.5, maximum O3 | FVC | β (PM2.5) = −0.1% (−0.8 to 0.5) | β (PM2.5) = −2.1% (−3.2 to −1.0) | |
| Studies reporting stronger effects among men | |||||
| 1,391 nonsmoking U.S. adults | IQR difference of 54.2 days/year > 100 μg/m3 PM10 | PPFEV1 | β = −7.2 (−11.5 to −2.7) (males w/parental respiratory illness) | β = 0.9 (−0.8 to 2.5) | |
| 520 nonsmoking undergraduate students in New Haven, CT | Lived ≥ 4 years in U.S. county with summer 1-hr O3 ≥ 80 ppb | Percent change in FEV1 | β = −4.7% (−0.7 to −8.8) | β = −0.26% (3.79 to −4.31) | |
| 530 hikers (18–64 years), Mt. Washington, NH | Ambient O3, PM2.5, aerosol acidity | Percent change in FEV1 | β = −0.055 (SE = 0.025) | β = −0.039 (SE = 0.039) | |
| 1,075 Chinese adults (35–60 years) | Ambient PM2.5 and SO2 (rural vs. urban area) | Mean change FEV1 | 199 mL (SE = 50 mL) | 87 mL (SE = 30 mL) | |
| Studies reporting null or mixed modification | |||||
| 9,651 adults 18–60 years of age in Switzerland (SAPALDIA cohort) | 10-μg/m3 change in annual mean PM10 | FVC | β = 3.4% ( | Effects did not differ by sex | |
| 6,913 adults (25–75 years) (NHANES I) | 1-SD increase in TSP (about 34 μg/m3) | Percent change in FVC | β = 2.25% ( | Effects did not differ by sex ( | |
| 584 men, 830 women in Krakow, Poland | Residence in area with higher sulfate or sulfur transformation ratio | Lung function, symptoms | FEV1 decline faster by 11 mL/year in high- vs. low-sulfate areas | High-sulfate area predicted symptoms, not lung function | |
| 1,485 Haarlem, Netherlands, adults | Living on heavy (vs. light) trafficked streets | Wheeze (ever) | OR = 1.1 (0.8–1.3) | Effects did not differ by sex | |
| 1.9 million deaths in 20 U.S. cities, 1989–2000 | 10-μg/m3 change in daily PM10 concentrations | Percent increase in respiratory mortality | β = 0.71 (0.004–1.42) | β = 1.04 (0.33–1.75) | |
Abbreviations: IQR, interquartile range; NHANES, National Health and Nutrition Examination Survey; NR, not reported; OR, odds ratio; PPFEV1, percent predicted FEV1; RR, relative risk; Q, quartile; SAPALDIA, Study on Air Pollution and Lung Diseases in Adults; TRS, total reduced sulfur; VC%, vital capacity percent. Key results demonstrate observed effect modification, and are not exhaustive of results reported for each study. Values in parentheses are 95% confidence intervals, unless otherwise indicated.
Other outcomes showed no significant effect modification by sex.
Effects did not differ by sex, and therefore are reported here in only one column.
Studies examining effect modification by sex among children.
| Study | Population | Exposure metric(s) | Outcome(s) of interest | Risk among males | Risk among females |
|---|---|---|---|---|---|
| Studies reporting stronger effects among girls | |||||
| 877 Dutch children (7–12 years of age) in 1995 | Truck traffic density (for children within 300 m of motorway) | Change in FVC | β = −1.1 (−6.7 to 4.9) | β = −6.3 (−11.4 to −0.8) | |
| 883 children (0–14 years of age) in Windsor, Ontario, Canada 1995–2000 | IQR increase in 1-, 2-, 3-day lag NO2, SO2, CO, COH, O3, PM10, TRS | RR of respiratory hospitalization | RR(lag1 SO2) = 0.95 (0.87 to 1.04) | RR(lag1 SO2) = 1.11 (1.01 to 1.22) | |
| 2,307 9- and 10-year-old children in Oslo, Norway | IQR increase in lifetime NO2, PM2.5, PM10 | Change in PEF | β (NO2) = −69.1 mL/sec (−135.3 to −3.0) | β (NO2) = −94.5 mL/sec (−166.6 to −22.4) | |
| 291 Haarlem, Netherlands, children (0–15 years of age) | Living on heavy (vs. light) trafficked streets | Wheeze (ever) | OR = 1.2 (0.4–3.7) | OR = 4.4 (1.4–13.6) | |
| 197 children (4 months to 4 years) hospitalized with wheeze, 350 controls | Residential outdoor NO2, presence of gas stove | RR of wheezing bronchitis | RR (NO2 > 0.7) = 0.7 (0.4–1.3); | RR (NO2 > 70) = 2.7 (1.1–6.8); | |
| 3,293 children in 12 Southern California communities | Lifetime ambient NO2, PM2.5, and O3 | FVC | β (NO2) = −29.9 L/min (SE = 29.5) | β (NO2) = −63.8 (SE = 18.3) | |
| 3,170 children (8 years of age) in Mexico City, 1996–1999 | IQR increase in mean O3, PM10, NO2 | Change in FEV1 | β (O3) = −4 mL (−10 to 2) | β (O3) = −12 mL (−18 to −6) | |
| 2,107 children 9–14 years of age in 40 Rome schools | Residential traffic | Percent difference in FEV1 | β = −4% (−29 to 21) | β = −23% (−49 to 2); | |
| 1,630 children (7–12 years of age) in rural Canada | High- vs. low-exposure community | Percent difference in FVC | β = 1.45% ( | β = 2.52% ( | |
| 1,498 children in 13 schools | Residence within 100 m of freeway | Chronic cough Wheeze | OR = 1.05 (0.50–2.22) | OR = 2.45 (1.16–5.16) | |
| Studies reporting stronger effects among boys | |||||
| 14 boys and 5 girls with asthma, 9–17 years of age | IQR increase in 4-day personal PM2.5 | FEV1 | β = −16% (−26 to −6) | β = −1% (−16 to 14) | |
| 1,756 German infants | Outdoor residential exposure gradient 1.5 μg/m3 in PM2.5, 0.4 × 10−5/m abs, 8.5 μg/m3 NO2 | Cough without infection | OR (PM2.5) = 1.43 (1.14–1.80) | OR (PM2.5) = 1.19 (0.84–1.70) | |
| 1,001 children in Krakow, Poland | Residence in high- vs. low-pollution area | Slower growth in FVC | OR (FVC) = 2.15 (1.25–3.69) | OR (FVC) = 1.50 (0.84–2.68) | |
| 3,676 children in 12 Southern California communities | IQR difference in community lifetime ambient acid, NO2, PM2.5, O3 | Prevalence of wheeze | OR (NO2) = 1.47 (1.04–2.09) | OR (NO2) = 0.85 (0.59–1.21) | |
| Studies reporting null or mixed modification | |||||
| 540 Stockholm children (0–2 years of age) | Indoor and outdoor residential NO2 | OR for recurrent wheeze (high vs. low quartile) | OR (outdoor NO2) = 1.60 (0.78–3.26) | NR; effects did not differ by sex | |
| 1,759 children in 12 Southern California communities | Lifetime community annual average NO2, PM2.5, EC (most vs. least polluted) | Growth in FVC | β (NO2) = −95.0 (−189.4 to −0.6) | NR; effects did not differ by sex | |
| 6,782 Toronto, Canada children, 0–14 years of age | 6.5 μg/m3 increase in 6-day PM10–2.5 exposure | Hospitalizations for respiratory infections | β = 1.15% ( 1.02–1.30) | β = 1.18% (1.01–1.36) | |
| 182 asthmatic children 9–14 years of age in Windsor, Ontario, Canada | IQR change in same-day, lagged SO2, NO2, O3, PM2.5 | Percent change in FEF25–75 | β (same-day NO2 ) = −2.4 (−4.3 to −0.4) | NR; effects did not differ by sex | |
| 1,621 children in 14 European centers, 1993–1994 | 24-hr measures of PM10, BS, SO2, NO2 | Change in evening PEF per 100 μg/m3 | β (lag 0 SO2) = 1.9 L/min ( | β (lag 0 SO2) = 1.4 (NS) | |
| 4,300 youths (6–24 years of age), NHANES II, 1976–1980 | Annual average SO2, NO2, TSP, O3 at monitors | Change in FVC | β (NO2) = −2.94 ( | NR; effects did not differ by sex | |
| 44 asthmatic children (< 14 years of age) | Daily personal NO2 exposure | Chest tightness | OR = 1.29 (1.16, 1.43) | NR; effects did not differ by sex | |
| 1,993 pupils (11–15 years of age) in urban China | School indoor and outdoor SO2, NO2, O3 | Asthma, wheeze | OR (wheeze, indoor SO2) = 1.18 (1.03–1.35) | NR; effects did not differ by sex | |
Abbreviations: abs, absorbance; BS, black smoke; CH2O, formaldehyde; EC, elemental carbon; IQR, interquartile range; MMEF, median mid-expiratory flow; NR, not reported; NS, not significant; OR, odds ratio; PEFR, peak expiratory flow rate; RR, relative risk; TRS, total reduced sulfur. Key results demonstrate observed effect modification, and are not exhaustive of results reported for each study. Values in parentheses are 95% confidence interval, unless otherwise indicated.
Effects did not differ by sex, and therefore are reported here in only one column.